Sotera Health Company's (SHC) stock plummeted by 5.06% in pre-market trading on Thursday, following the release of its fourth-quarter 2024 financial results. The healthcare company reported mixed results for the quarter, with earnings per share beating analyst estimates by a narrow margin but revenue falling short of expectations.
The company reported adjusted earnings of $0.21 per share, surpassing the consensus estimate of $0.20 by 5%. However, revenue for the quarter declined by 6.5% year-over-year to $290.2 million, missing the analyst consensus of $290.88 million. Furthermore, Sotera Health's guidance for 2025 adjusted earnings per share of $0.70 to $0.76 fell short of analyst expectations of $0.78.
The disappointing revenue performance and weaker-than-expected outlook for 2025 appear to have dampened investor sentiment, leading to the significant pre-market sell-off in Sotera Health's shares. Despite the mixed results, analysts maintained an overall "buy" rating on the stock, indicating confidence in the company's long-term prospects.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.